Biotestx ApS: Financial statements 2020
CVR: 37965014
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Biotestx ApS (CVR 37965014) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -2,682 compared with DKK 33,346 the year before. Equity in the 2020 report amounted to DKK 78,265. The solvency ratio was 80.9%.
- Profit/Loss
- DKK -2,682
- Equity
- DKK 78,265
- Total Assets
- DKK 96,729
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -3 t. | 78 t. | 0 |
| 2019 | - | - | 33 t. | 81 t. | 0 |
| 2018 | - | - | 24 t. | 48 t. | 0 |
Official annual report
How creditworthy is Biotestx ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biotestx ApS has published its annual report for 2019. The net result was DKK 33,346.
About Biotestx ApS
Biotestx ApS was a Danish company of the type Anpartsselskab based in Risskov, founded in 2016. The company has been dissolved on 5 December 2023. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -4,600 and a net result of DKK -83,106 compared with DKK -21,564 the year before. Equity in the 2022 report amounted to DKK -26,405.